KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E Adjustments
Ratios

Bausch Health Companies (BHC) R&D In Process: 2009-2019

Historic R&D In Process for Bausch Health Companies (BHC) over the last 3 years, with Mar 2019 value amounting to $1.0 million.

  • Bausch Health Companies' R&D In Process changed negligibly% to $1.0 million in Q1 2019 from the same period last year, while for Mar 2019 it was $18.0 million, marking a year-over-year decrease of 47.06%. This contributed to the annual value of $1.0 million for FY2018, which is 80.00% down from last year.
  • Per Bausch Health Companies' latest filing, its R&D In Process stood at $1.0 million for Q1 2019, which was down 0.00% from $1.0 million recorded in Q1 2018.
  • In the past 5 years, Bausch Health Companies' R&D In Process registered a high of $95.8 million during Q3 2015, and its lowest value of -$20.0 million during Q4 2016.
  • Moreover, its 2-year median value for R&D In Process was $1.0 million (2019), whereas its average is $1.0 million.
  • As far as peak fluctuations go, Bausch Health Companies' R&D In Process spiked by 381.41% in 2015, and later tumbled by 852.38% in 2016.
  • Bausch Health Companies' R&D In Process (Quarterly) stood at -$2.1 million in 2015, then crashed by 852.38% to -$20.0 million in 2016, then reached $1.0 million in 2018, then remained steady at $1.0 million in 2019.
  • Its last three reported values are $1.0 million in Q1 2019, $1.0 million for Q1 2018, and -$20.0 million during Q4 2016.